Article
Histone Deacetylase Inhibitors for Peripheral T-cell Lymphomas: From Biology to Real-World Therapy
2024-08-12
Abstract excerpt
Histone deacetylase inhibitors (HDACis) are being recognized as a potentially effective treatment approach for peripheral T-cell lymphoma (PTCL), which is a diverse group of aggressive lymphomas with a bleak prognosis. Recent evidence has shown that HDACi are effective in treating PTCL, especially in cases where the disease has relapsed or is resistant to other treatments, and there are few available options. Seve...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 13acc3fa-5d8b-54ad-9449-37715e813260
- DOI
- 10.20944/preprints202408.0744.v1
